Filler BMJ updates

Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39234.488356.DE (Published 05 July 2007) Cite this as: BMJ 2007;335:36

Abstract

Research question Is once yearly intravenous zoledronic acid an effective treatment for postmenopausal osteoporosis?

Answer Yes. Yearly treatment prevents fractures and increases bone mineral density compared with a placebo.

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe